T. Yau

670 total citations
18 papers, 504 citations indexed

About

T. Yau is a scholar working on Oncology, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T. Yau has authored 18 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Hepatology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T. Yau's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer survivorship and care (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). T. Yau is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer survivorship and care (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). T. Yau collaborates with scholars based in China, Hong Kong and Singapore. T. Yau's co-authors include Inda Soong, Winnie Yeo, Ava Kwong, Dacita Suen, Joyce Suen, Janice Tsang, Anne W.M. Lee, Wwt Lam, Michael C.H. Lee and Wai Tong Ng and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Yau

18 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Yau China 12 303 107 105 94 91 18 504
Trille Kristina Kjær Denmark 15 303 1.0× 120 1.1× 56 0.5× 187 2.0× 104 1.1× 38 666
Maja Halgren Olsen Denmark 12 291 1.0× 61 0.6× 53 0.5× 66 0.7× 78 0.9× 29 441
Inda Soong China 18 540 1.8× 132 1.2× 200 1.9× 138 1.5× 173 1.9× 42 893
Giovanni Rosti Italy 16 521 1.7× 105 1.0× 85 0.8× 129 1.4× 65 0.7× 43 757
Kerry L. Beckman United States 6 241 0.8× 150 1.4× 50 0.5× 46 0.5× 77 0.8× 8 551
Lia C.G. Verhoef Netherlands 16 144 0.5× 57 0.5× 71 0.7× 55 0.6× 122 1.3× 19 702
Anne Mette Tranberg Kejs Denmark 14 251 0.8× 113 1.1× 75 0.7× 186 2.0× 106 1.2× 27 674
Wing Kin Sze China 11 212 0.7× 99 0.9× 73 0.7× 57 0.6× 55 0.6× 12 441
Adam Roughley United Kingdom 7 272 0.9× 236 2.2× 41 0.4× 80 0.9× 90 1.0× 15 561
V. Duric Australia 11 398 1.3× 112 1.0× 83 0.8× 68 0.7× 79 0.9× 17 716

Countries citing papers authored by T. Yau

Since Specialization
Citations

This map shows the geographic impact of T. Yau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Yau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Yau more than expected).

Fields of papers citing papers by T. Yau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Yau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Yau. The network helps show where T. Yau may publish in the future.

Co-authorship network of co-authors of T. Yau

This figure shows the co-authorship network connecting the top 25 collaborators of T. Yau. A scholar is included among the top collaborators of T. Yau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Yau. T. Yau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Lam, Wwt, Ava Kwong, Dacita Suen, et al.. (2018). Factors predicting patient satisfaction in women with advanced breast cancer: a prospective study. BMC Cancer. 18(1). 162–162. 19 indexed citations
3.
Meyer, Tim, Ignacio Melero, T. Yau, et al.. (2018). Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study. Journal of Hepatology. 68. S16–S16. 8 indexed citations
4.
Sangro, Bruno, T. Yau, Chia‐Wei Hsu, et al.. (2017). Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study. Journal of Hepatology. 66(1). S34–S35. 5 indexed citations
5.
Abou-Alfa, G.K., Jonghun Yoon, Manuel Modiano, et al.. (2016). An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma. European Journal of Cancer. 69. S22–S22. 3 indexed citations
6.
Lam, Wwt, Winnie Yeo, Joyce Suen, et al.. (2015). Goal adjustment influence on psychological well‐being following advanced breast cancer diagnosis. Psycho-Oncology. 25(1). 58–65. 27 indexed citations
7.
Lam, Wwt, Janice Tsang, Winnie Yeo, et al.. (2013). The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis. Supportive Care in Cancer. 22(3). 635–644. 38 indexed citations
9.
Lam, Wwt, Inda Soong, T. Yau, et al.. (2013). The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: a longitudinal study. Psycho-Oncology. 22(12). 2831–2839. 78 indexed citations
10.
Ho, Samuel M. Y., et al.. (2010). Relationships between explanatory style, posttraumatic growth and posttraumatic stress disorder symptoms among Chinese breast cancer patients. Psychology and Health. 26(3). 269–285. 39 indexed citations
11.
Au, Angel Hoe-chi, Wwt Lam, Ava Kwong, et al.. (2010). Validation of the Chinese version of the Short‐form Supportive Care Needs Survey Questionnaire (SCNS‐SF34‐C). Psycho-Oncology. 20(12). 1292–1300. 77 indexed citations
12.
Yau, T., et al.. (2009). 47LBA Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma. European Journal of Cancer Supplements. 7(3). 20–21. 13 indexed citations
13.
Ng, Wai Tong, Oscar S.H. Chan, Anne W.M. Lee, et al.. (2008). Parapharyngeal Extension of Nasopharyngeal Carcinoma: Still a Significant Factor in Era of Modern Radiotherapy?. International Journal of Radiation Oncology*Biology*Physics. 72(4). 1082–1089. 29 indexed citations
14.
Chan, Oscar S.H., Wai Tong Ng, Michael C.H. Lee, et al.. (2008). Sensorineural Hearing Loss After Treatment of Nasopharyngeal Carcinoma: A Longitudinal Analysis. International Journal of Radiation Oncology*Biology*Physics. 73(5). 1335–1342. 88 indexed citations
15.
Yau, T., et al.. (2008). HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.. PubMed. 14(2). 130–5. 14 indexed citations
16.
Pang, E., et al.. (2006). 2373. International Journal of Radiation Oncology*Biology*Physics. 66(3). S417–S418. 3 indexed citations
17.
Yau, T., et al.. (2001). MRI of the hypothalamus and pituitary gland in patients with hyperprolactinaemia following radiotherapy for nasopharyngeal carcinoma.. PubMed. 42(9). 406–9. 2 indexed citations
18.
Wong, K. F., et al.. (1994). Primary Cutaneous Plasmacytoma—Report of Two Cases and Review of the Literature. American Journal of Dermatopathology. 16(4). 392–397. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026